# Panitumumab in Children With Solid Tumors

> **NCT00658658** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 31 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **BIOLOGICAL:** Panitumumab

## Key facts

- **NCT ID:** NCT00658658
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658658, "Panitumumab in Children With Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00658658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*